Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
UBS
Julphar
Novartis
Moodys
Chubb
Queensland Health
Cantor Fitzgerald
Dow

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,569,652

« Back to Dashboard

Summary for Patent: 5,569,652
Title: Dihydrospirorenone as an antiandrogen
Abstract:Dihydrospirorenone, ##STR1## preferably together with an estrogen, can be used for the production of a pharmaceutical agent suitable for treatment of hormonal irregularities during premenopause (menstruation stabilization), for hormonal substitution therapy during menopause, for treatment of androgen-induced disorders and/or for contraception.
Inventor(s): Beier; Sybille (Berlin, DE), Elger; Walter (Berlin, DE), Nishino; Yukishige (Berlin, DE), Wiechert; Rudolf (Berlin, DE)
Assignee: Schering Aktiengesellschaft (Berlin, DE)
Application Number:08/162,387
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,569,652

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,569,652

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany39 16 112.9May 16, 1989

International Patents Family Members for US Patent 5,569,652

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 154881 ➤ Try a Free Trial
Australia 5509490 ➤ Try a Free Trial
Australia 642876 ➤ Try a Free Trial
Brazil 1101055 ➤ Try a Free Trial
Canada 2016780 ➤ Try a Free Trial
China 1033948 ➤ Try a Free Trial
China 1047299 ➤ Try a Free Trial
German Democratic Republic 294417 ➤ Try a Free Trial
Germany 122004000006 ➤ Try a Free Trial
Germany 3916112 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Dow
Healthtrust
Cerilliant
Teva
Harvard Business School
Citi
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot